[go: up one dir, main page]

TW200505866A - Novel imidazopyridine compound iii with therapeutic effect - Google Patents

Novel imidazopyridine compound iii with therapeutic effect

Info

Publication number
TW200505866A
TW200505866A TW093117965A TW93117965A TW200505866A TW 200505866 A TW200505866 A TW 200505866A TW 093117965 A TW093117965 A TW 093117965A TW 93117965 A TW93117965 A TW 93117965A TW 200505866 A TW200505866 A TW 200505866A
Authority
TW
Taiwan
Prior art keywords
therapeutic effect
compound iii
imidazopyridine compound
novel imidazopyridine
gastric acid
Prior art date
Application number
TW093117965A
Other languages
Chinese (zh)
Inventor
Peter Nordberg
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of TW200505866A publication Critical patent/TW200505866A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to imidazo pyridine derivatives of the Formula I which inhibit exogenously or endogenously stimulated gastric acid secretion and thus can be used in the prevention and treatment of gastric acid related diseases and gastrointestinal inflammatory diseases.
TW093117965A 2003-06-26 2004-06-21 Novel imidazopyridine compound iii with therapeutic effect TW200505866A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0301903A SE0301903D0 (en) 2003-06-26 2003-06-26 Novel imidazopyridine compound III with therapeutic effect

Publications (1)

Publication Number Publication Date
TW200505866A true TW200505866A (en) 2005-02-16

Family

ID=27656636

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093117965A TW200505866A (en) 2003-06-26 2004-06-21 Novel imidazopyridine compound iii with therapeutic effect

Country Status (4)

Country Link
SE (1) SE0301903D0 (en)
TW (1) TW200505866A (en)
UY (1) UY28383A1 (en)
WO (1) WO2004113340A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20086158A0 (en) * 2008-12-03 2008-12-03 Mikael Dahlstroem imidazopyridine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801526D0 (en) * 1998-04-29 1998-04-29 Astra Ab New compounds

Also Published As

Publication number Publication date
WO2004113340A1 (en) 2004-12-29
SE0301903D0 (en) 2003-06-26
UY28383A1 (en) 2005-01-31

Similar Documents

Publication Publication Date Title
MX2011005769A (en) Imidazopyridine derivatives which inhibit the secretion of gastric acid.
MY121389A (en) Imidazo pyridine derivatives which inhibit gastric acid secretion
SE9700661D0 (en) New compounds
MXPA04001402A (en) Novel imidazopyridine compounds with therapeutic effect.
SE9704404D0 (en) New compounds
NO20082594L (en) Pyrimidinylbenzotiofenforbindelser
MY149957A (en) Heterocyclic inhibitors of mek and methods of use thereof
NO20064120L (en) 3,4-heterocyclyl-1,2,3-triazol-1-yl-N-aryl-benzamide are inhibitors of cytokine production for the treatment of chronic inflammatory diseases
SE9401197D0 (en) Active compounds
TW200505904A (en) Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
SE9802794D0 (en) New compounds
SE9602286D0 (en) New compounds
NO20064732L (en) Alpha-aminoamide derivatives are useful in the treatment of troubled bone syndrome and additive disorders
SE9802793D0 (en) New compounds
ECSP055844A (en) NEW TRICYCLE COMPOUNDS
TW200508234A (en) Novel imidazopyridine compound I with therapeutic effect
MY140718A (en) Novel imidazopyridine compound ii with therapeutic effect
NO20064632L (en) Tricyclic imidazopyridines
TW200505866A (en) Novel imidazopyridine compound iii with therapeutic effect
NO20063220L (en) Tricyclic imidazopyridines for use as gastric secretion inhibitors
AR044854A1 (en) IMIDAZOPIRIDINE COMPOUND
NO20065200L (en) Dialkoxy imidazopyridine
NO20072340L (en) Difluoro-substituted imidazopyridines
GB0307067D0 (en) Use of thiazolobenzoheterocycles for treating multiple sclerosis